The weight loss drug Wegovy treated a serious form of liver disease in about two-thirds of patients in a major clinical trial, according to the findings published Wednesday in the New England ...

In a late-stage clinical trial, Wegovy (semaglutide) significantly reduced liver inflammation and reversed scarring in people with the liver disease MASH. MASH is associated with obesity and type ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by a common condition. By Dani Blum I’ve reported on Ozempic since 2022. New research shows ...

The drug may treat multiple conditions at once, says Grace Su, president of the American Association for the Study of Liver Diseases. Novo Nordisk, the company that makes Ozempic and Wegovy ...

A recommended 150 minutes per week at moderate intensity can help reduce liver inflammation and rid the organ of fat. Antioxidants and other compounds in coffee (even decaf) can help protect against ...